These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 15364432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse.
    Wu CY, Lin YW, Kuo CH, Liu WH, Tai HF, Pan CH, Chen YT, Hsiao PW, Chan CH, Chang CC, Liu CC, Chow YH, Chen JR.
    PLoS One; 2015; 10(8):e0136420. PubMed ID: 26287531
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
    Wang KT, Lin SJ, Wang HC, Chen PC, Lin JJ, Chiang JR, Chang CL, Shih DY, Lo CF, Wang DY.
    Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
    [Abstract] [Full Text] [Related]

  • 7. Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.
    Chou AH, Liu CC, Chang CP, Guo MS, Hsieh SY, Yang WH, Chao HJ, Wu CL, Huang JL, Lee MS, Hu AY, Lin SC, Huang YY, Hu MH, Chow YH, Chiang JR, Chang JY, Chong P.
    PLoS One; 2012 Jul; 7(4):e34834. PubMed ID: 22529942
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.
    Lin YC, Wu CN, Shih SR, Ho MS.
    Vaccine; 2002 Jun 07; 20(19-20):2485-93. PubMed ID: 12057603
    [Abstract] [Full Text] [Related]

  • 9. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.
    Cheng A, Fung CP, Liu CC, Lin YT, Tsai HY, Chang SC, Chou AH, Chang JY, Jiang RH, Hsieh YC, Su IJ, Chong PC, Hsieh SM.
    Vaccine; 2013 May 07; 31(20):2471-6. PubMed ID: 23541623
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.
    Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wang YC, Chen YC, Yang CS, Chong PC.
    PLoS One; 2011 May 07; 6(5):e20005. PubMed ID: 21603631
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process.
    Liu CC, Chang HW, Yang G, Chiang JR, Chow YH, Sai IH, Chang JY, Lin SC, Sia C, Hsiao CH, Chou AH, Chong P.
    J Virol Methods; 2011 Sep 07; 176(1-2):60-8. PubMed ID: 21704080
    [Abstract] [Full Text] [Related]

  • 15. Selection and characterization of vaccine strain for Enterovirus 71 vaccine development.
    Chang JY, Chang CP, Tsai HH, Lee CD, Lian WC, Ih-Jen-Su, Sai IH, Liu CC, Chou AH, Lu YJ, Chen CY, Lee PH, Chiang JR, Chong PC.
    Vaccine; 2012 Jan 17; 30(4):703-11. PubMed ID: 22142585
    [Abstract] [Full Text] [Related]

  • 16. [Immunoprotective effect of inactivated coxsackievirus A16 vaccine in mice].
    Chen XP, Tan XJ, Zhang Y, Xu WB.
    Bing Du Xue Bao; 2014 May 17; 30(3):226-32. PubMed ID: 25118375
    [Abstract] [Full Text] [Related]

  • 17. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY, Weng TC, Tseng YF, Chen YS, Wu CH, Hsiao S, Chou AH, Chao HJ, Gu A, Wu SC, Chong P, Lee MS.
    Vaccine; 2008 Oct 23; 26(45):5736-40. PubMed ID: 18761387
    [Abstract] [Full Text] [Related]

  • 18. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
    Cai Y, Ku Z, Liu Q, Leng Q, Huang Z.
    Vaccine; 2014 May 01; 32(21):2406-12. PubMed ID: 24657161
    [Abstract] [Full Text] [Related]

  • 19. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles.
    Lin YL, Yu CI, Hu YC, Tsai TJ, Kuo YC, Chi WK, Lin AN, Chiang BL.
    Vaccine; 2012 Feb 08; 30(7):1305-12. PubMed ID: 22214888
    [Abstract] [Full Text] [Related]

  • 20. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
    Liu CC, Chow YH, Chong P, Klein M.
    Vaccine; 2014 Oct 29; 32(47):6177-82. PubMed ID: 25218294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.